Welcome to MyIDSA

Welcome to MyIDSA, IDSA’s Member-Only Community! Connect with Colleagues, Share Resources, Start or Join a Lively Discussion. Join us…It’s Infectious!


Recent Discussions

  • Posted in: IDea Exchange

    ​Our hospital is trying to institute a policy for safe discharge of patients with current and past history of IVDU who need IV antibiotics and PICC/midline. I wanted to know the experience of members here with respect to having such a policy. The hospital ...

  • Posted in: IDea Exchange

    Maybe it's time for an older voice praising the  "hard copy" of  JID.  Do our baby boomer and millennial colleagues not know the joy and discovery of "curling up with a book" and "flipping through the pages of a magazine"?  Do they not ever take their ...

  • Posted in: IDea Exchange

    Is anyone aware of any blood testing that may be worthwhile?  We collected EDTA and serum separator gold top tubes immediately prior to infusion and during the reaction, and would be happy to send them out.  Did this today on a patient who we brought ...

New Guidelines Update

IDSA, ASTMH Neurocysticercosis Guideline


Practice Guidelines

Member Spotlight

Kim Hanson, MD

IDSA Diagnostics Committee Chair Kim Hanson, MD, has been appointed to the Centers for Medicare and Medicaid (CMS) Advisory Panel on Clinical Diagnostic Laboratory Tests following a nomination from IDSA. The Panel advises the CMS Administrator and the Secretary of the Department of Health and Human Services on issues related to clinical diagnostic laboratory tests, including the establishment of payment rates and the factors used in determining coverage and payment processes for new tests.

Dr. Hanson is the head of Immunocompromised Host Infectious Diseases Services and Director of the Medical Microbiology Fellowship Program at the University of Utah, as well as Director of Clinical Microbiology at ARUP Laboratories. She is an associate professor of medicine and pathology, splitting her time between patient care, laboratory administration, research, and teaching.


  • Battling superbugs requires buy-in from across the healthcare system, experts say

    Addressing antibiotic resistance and the dearth of new drugs in development is a global concern, and the issue will require buy-in from stakeholders ...
  • Modeling tool tells when pairing responses to “big three” and neglected diseases is a win-win

    The idea of pairing responses to diseases found in the global south that are so neglected that they are classified by that word with the better-funded, ...

Help attract the best and brightest to the field of infectious diseases.

IDSA Foundation

Upcoming Events

  • Wednesday

    IDWeek 2018

    Wednesday, October 3 - Sunday, October 7, 2018
    Registration will open for members on March 6, and to everyone on April 3.
    San Francisco, CA, United States

IDSA has been important in my career in infectious disease. IDSA also plays a big role in advocacy and drawing attention to key issues. It's exciting to be a part of that and feel that I have an avenue for my voice to be heard.
Ingrid Bassett, MD, MPH, FIDSA
The idea that I could link epidemiology with my fundamental knowledge of how microorganisms work, along with diagnostic microbiology...this is an amazing way to put the pieces of the puzzles together about how infectious diseases work in human beings.
Lucy Tompkins, MD, PhD, FIDSA
I always like mystery stories growing up and you have to be very astute...You have to look at the symptoms, the geography, the home and social situation to solve the mystery of their problem.
Susan Bleasdale, MD
You can take a patient in front of you, and within a short amount of time with your clinical care, have an enormous impact.
John Lynch, MD, MPH
Understanding the pathogenesis of infectious diseases requires a knowledge of pathology, immunology, especially microbiology. The discipline allows practitioners to combine all of those, and there's never a dull moment.
Philip Polgreen, MD, MPH
I just became a member of IDSA this year, and I find it amazing how supportive IDSA has been to me so far.
Noah Kojima, MD